EA201590856A1 - Получение живых вакцин - Google Patents

Получение живых вакцин

Info

Publication number
EA201590856A1
EA201590856A1 EA201590856A EA201590856A EA201590856A1 EA 201590856 A1 EA201590856 A1 EA 201590856A1 EA 201590856 A EA201590856 A EA 201590856A EA 201590856 A EA201590856 A EA 201590856A EA 201590856 A1 EA201590856 A1 EA 201590856A1
Authority
EA
Eurasian Patent Office
Prior art keywords
live vaccines
receiving live
vaccine containing
bacterium
receiving
Prior art date
Application number
EA201590856A
Other languages
English (en)
Other versions
EA030355B1 (ru
Inventor
Клаус Линде
Анке Гроссе-Херрентей
Original Assignee
Ломанн Энимал Хелс Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ломанн Энимал Хелс Гмбх filed Critical Ломанн Энимал Хелс Гмбх
Priority claimed from PCT/EP2013/068373 external-priority patent/WO2014037445A1/en
Publication of EA201590856A1 publication Critical patent/EA201590856A1/ru
Publication of EA030355B1 publication Critical patent/EA030355B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/42—Salmonella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Описан способ получения живой вакцины, содержащей стабильную бактерию, несущую по меньшей мере три аттенюирующих мутации, и вакцины, содержащей бактерию, полученную указанным способом.
EA201590856A 2012-12-07 2013-09-05 Получение живых вакцин EA030355B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12008206 2012-12-07
PCT/EP2013/068373 WO2014037445A1 (en) 2012-09-05 2013-09-05 Preparation of live vaccines

Publications (2)

Publication Number Publication Date
EA201590856A1 true EA201590856A1 (ru) 2015-09-30
EA030355B1 EA030355B1 (ru) 2018-07-31

Family

ID=47355770

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201590856A EA030355B1 (ru) 2012-12-07 2013-09-05 Получение живых вакцин

Country Status (15)

Country Link
US (3) US10828362B2 (ru)
EP (3) EP3714899A1 (ru)
JP (1) JP6336461B2 (ru)
KR (1) KR101835946B1 (ru)
CN (2) CN104995292A (ru)
AU (2) AU2013311675A1 (ru)
BR (1) BR112015011944A8 (ru)
CA (1) CA2901322C (ru)
EA (1) EA030355B1 (ru)
ES (2) ES2686325T3 (ru)
HK (1) HK1213949A1 (ru)
MX (1) MX368393B (ru)
NZ (1) NZ709154A (ru)
PL (2) PL3415643T3 (ru)
PT (1) PT2929058T (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX368393B (es) * 2012-12-07 2019-10-01 Lohmann Animal Health Gmbh Preparacion de vacunas vivas.
CN114107162A (zh) * 2021-12-08 2022-03-01 塔里木大学 诱导细菌形成小菌落变异体的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE294420C (ru)
DE3751641D1 (de) * 1986-10-10 1996-02-01 Tad Pharm Werk Salmonella-Lebendimpfstoffe mit Wirtsspezies-angepassten Attenuierungshöhen und antiepidemischer Potenz
US5112749A (en) * 1987-10-02 1992-05-12 Praxis Biologics, Inc. Vaccines for the malaria circumsporozoite protein
DD294420A5 (de) * 1990-05-18 1991-10-02 Karl-Marx-Universitaet Leipzig,De Verfahren zur herstellung von lebendimpfstoffen gegen listeriose
CA2097931C (en) * 1990-12-18 2003-07-29 Samuel I. Miller, Iii Salmonella vaccines
US6136325A (en) 1993-04-09 2000-10-24 Lohmann Animal Health Gmbh & Co. Kg Live vaccine constituting minor risk for humans
ES2168265T3 (es) * 1993-09-04 2002-06-16 Lohmann Animal Health Gmbh Vacuna viva de salmonella.
DE4333742A1 (de) * 1993-10-04 1995-04-06 Klaus Prof Dr Linde Lebendimpfstoff mit erhöhter Stabilität
US6479056B1 (en) 1994-09-02 2002-11-12 Lohman Animal Health Gmbh & Co. Kg Live vaccine constituting minor risk for humans
GB9806449D0 (en) * 1998-03-25 1998-05-27 Peptide Therapeutics Ltd Attenuated bacteria useful in vaccines
GB0024203D0 (en) * 2000-10-03 2000-11-15 Peptide Therapeutics Ltd Stabilisation of plasmid inheritance in bacteria
US20050180985A9 (en) * 2001-10-04 2005-08-18 Vladoianu Ion R. Live attenuated salmonella strains for producing monovalent or multivalent vaccines
GB0308691D0 (en) * 2003-04-07 2003-05-21 Xenova Res Ltd Vaccine preparations
NZ549084A (en) * 2004-02-12 2009-10-30 Univ Queensland Live attenuated salmonella for use as vaccine
UA100370C2 (uk) * 2006-12-11 2012-12-25 Мериал Лимитед Спосіб вакцинації птахів проти salmonella
DE102007012824A1 (de) * 2007-03-17 2008-09-18 Universität Leipzig Impfstämme mit abgestuften Koloniegrößen/Attenuierungen und Verfahren zu deren Isolierung
DE102008062941A1 (de) * 2008-12-23 2010-07-01 Universität Leipzig Impfstämme gegen bakterielle und fungale Infektionen
MX368393B (es) * 2012-12-07 2019-10-01 Lohmann Animal Health Gmbh Preparacion de vacunas vivas.

Also Published As

Publication number Publication date
AU2013311675A1 (en) 2015-05-21
PL3415643T3 (pl) 2020-06-01
US20240181031A1 (en) 2024-06-06
US20220088168A1 (en) 2022-03-24
EP2929058A1 (en) 2015-10-14
EP3714899A1 (en) 2020-09-30
BR112015011944A2 (pt) 2017-07-11
CN112760252A (zh) 2021-05-07
JP6336461B2 (ja) 2018-06-06
US20150297705A1 (en) 2015-10-22
EP2929058B1 (en) 2018-07-11
EP3415643B1 (en) 2020-02-19
JP2015536142A (ja) 2015-12-21
ES2686325T3 (es) 2018-10-17
US11904008B2 (en) 2024-02-20
PL2929058T3 (pl) 2018-11-30
CA2901322C (en) 2019-07-02
KR20150082480A (ko) 2015-07-15
KR101835946B1 (ko) 2018-03-07
ES2776429T3 (es) 2020-07-30
MX2015007195A (es) 2016-03-07
BR112015011944A8 (pt) 2019-10-08
AU2017219152B2 (en) 2019-05-16
MX368393B (es) 2019-10-01
NZ709154A (en) 2019-10-25
AU2017219152A1 (en) 2017-09-21
EA030355B1 (ru) 2018-07-31
CA2901322A1 (en) 2014-03-13
EP3415643A1 (en) 2018-12-19
CN104995292A (zh) 2015-10-21
US10828362B2 (en) 2020-11-10
PT2929058T (pt) 2018-07-27
HK1213949A1 (zh) 2016-07-15

Similar Documents

Publication Publication Date Title
EA201300915A1 (ru) Новый европейский штамм prrsv
CL2018001000A1 (es) Anticuerpos y conjugados de anticuerpo y fármaco anti-egfr.
EA201491811A1 (ru) АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ
EA202092987A3 (ru) Липид, содержащий докозапентаеновую кислоту
EA201590424A1 (ru) Пирролбензодиазепины и их конъюгаты
MX2019002979A (es) Formulaciones de anticuerpos.
EP3071229A4 (en) Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants
UY34456A (es) Anticuerpos anti-il-36r
EA201491947A1 (ru) Антитела и иммуноконъюгаты к ly6e и способы применения
EA201691216A1 (ru) Композиции линаклотида с замедленным высвобождением
MX2020002544A (es) Sales de glicopirrolato.
UY34582A (es) Anticuerpos anti-cxcr3
MX349119B (es) Vacuna de virus de dengue inactivado.
UA117565C2 (uk) Модифікований олігонуклеотид
TN2013000378A1 (en) Anti - sclerostin antibody crystals and formulations thereof
EA201691363A1 (ru) Стабилизированные силикатные композиции и их применение в качестве антиперспирантных композиций
PH12015501171A1 (en) Device for conveying fuels into a gasification reactor
NZ710744A (en) Methods for increasing immunoglobulin a levels
GB201017519D0 (en) Vaccines
EA201692288A1 (ru) Способ получения фосфорсодержащих циангидринов
UY34286A (es) Diagnóstico de vacuna mejorado
UY34679A (es) ?PROCEDIMIENTO PARA OBTENER UNA COMPOSICIÓN DE IgG MEDIANTE TRATAMIENTO TÉRMICO?
EA201590116A1 (ru) Способ получения замещенных триазолопиридинов
EA201590856A1 (ru) Получение живых вакцин
BR112015017420A2 (pt) recombinação de vírus influenza

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY